Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus

Journal of Neural Transmission, Supplementa

Volumn , Issue 72, 2007, Pages 235-240

  Tahirovic, I ^a   Sofic, E ^a   Sapcanin, A ^a   Gavrankapetanovic, I ^a   Bach Rojecky, L ^b   Salkovic Petrisic, M ^c   Lackovic, Z ^c   Hoyer, S ^d   Riederer, P ^e  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

antioxidant capacity; diabetes mellitus; oxidative stress; Rat; streptozotocin

Indexed keywords

5-THIO-D-GLUCOSE; DRUG DERIVATIVE; FREE RADICAL; GLUCOSE; GLUCOSE TRANSPORTER; HYDROXYL RADICAL; NEUROTOXIN; PERHYDROXYL RADICAL; PEROXIDE; STREPTOZOCIN; THIOGLUCOSE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BRAIN; BRAIN STEM; CEREBELLUM; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METABOLISM; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; WISTAR RAT;

ALZHEIMER DISEASE; ANIMALS; BLOOD GLUCOSE; BRAIN; BRAIN STEM; CEREBELLUM; DIABETES MELLITUS, EXPERIMENTAL; FREE RADICALS; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HIPPOCAMPUS; HYDROXYL RADICAL; INJECTIONS, INTRAVENTRICULAR; INSULIN-SECRETING CELLS; MALE; NEUROTOXINS; OXIDATIVE STRESS; PEROXIDES; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 38449117894     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-73574-9_29     Document Type: Article

References (38)

1. Altan N, Dinçel AS, Koca C (2006) Diabetes mellitus and oxidative stress. Turk J Biochem 31:51-56
2. Bach-Rojecky L, Lackovic Z (2005) Antinociceptive effect of botulinum toxin type A in rat model of carrageenan and capsaicin induced pain. Croat Med J 46:201-208
3. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH (2002) Ageing and diabetes: implications for brain function. Eur J Pharmacol 441:1-14
4. Bronstein IN, Semendjajev KA (1962) Matematički priručnik za inženjere i studente. Tehnička knjiga, Zagreb, S457
5. Cao G, Alessio HM, Cutler RG (1993) Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 14:303-311
6. Cao G, Verdon C, Wu AHB, Wang H, Prior RL (1995) Automated oxygen radical absorbance capacity assay using the COBAS FARA II. Clin Chem 41:1738-1744
7. Cao G, Giovanoni M, Prior R (1996) Antioxidant capacity in different tissues of young and old rats. Proc Soc Exp Biol Med 211:359-365
8. Cao G, Sofic E, Prior R (1997) Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 22:749-760
9. Danova K, Dobisova A, Fischer V, Halcak L, Minarova H, Olejarova I, Pechan I (2005) Production of reactive oxygen species and antioxidant defense systems in patients after coronary artery bypass grafting: oneweek follow-up study. J Clin Basic Cardiol 8:33-36
10. Ding A, Nitsch R, Hoyer S (1992) Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injections of streptozotocin. J Cereb Blood Floow Metabol 12:103-109
11. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622
12. Gernot P (1977) Proteine. In: Clinische Chemie, Kurzlehrbuch und Kommentar zum Gegenstandskatalog für den Ersten Abschnitt der Ärztlichen Prüfung, 1. Aufla Rathgeber, Munchen, pp 308-367
13. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101:757-770
14. Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105:415-422
15. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102
16. Kumar JS, Menon VP (1993) Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 42(11):1435-1439
17. Kuyvenhoven JP, Meinders AE (1999) Oxidative stress and diabetes mellitus. Pathogenesis of long-term complications. Eur J Intern Med 10:9-19
18. Lacković Z, Šalković M (1990) Streptozocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. Life Sci 46:49-54
19. Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199-1208
20. Mariani E, Polidori MC, Cherubini A, Meccoci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827:65-75
21. McEwen BS, Reagan LP (2004) Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 490:13-24
22. Noble EP, Wurtman RJ, Axelrod J (1967) A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain. Life Sci 6:281-291
23. Ohkuwa T, Sato Y, Naoi M (1995) Hydroxylradical formation in diabetic rats induced by streptozotocin. Life Sci 56(21):1789-1798
24. Ou B, Hampsch-Woodill M, Prior RL (2001) Development and validation of an improved Oxygen Radical Absorbance Capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 49:4619-4626
25. Prickaerts J, Fahring T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav Brain Res 102:73-88
26. Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, Howard L, Hampsch-Woodill M, Huang D, Ou B, Jacob R (2003) Assays for hydrophilic and lipophilic antioxidant capacity [oxygen radical absorbance capacity (ORAC-FL)] of plasma and other biological and food samples. J Agric Food Chem 21:3273-3279
27. Randall LO, Selitto JJ (1957) A method for measurements of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111:409-419
28. Salkovic M, Sabolic I, Lackovic Z (1995) Striatal D1 and D2 receptors after intracerebroventricular applications of alloxan and streptozotocin in rat. J Neural Transm 100:127-145
29. Salkovic-Petrisic M, Lackovic Z (2003) Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes. J Neural Transm 110:15-29
30. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96:1005-1015
31. Sharma M, Gupta YK (2001) Effect of chronic treatment of melatoninon learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol Biochem Behav 70:325-331
32. Sharma RK, Pasqualotto FF, Nelson DR, Thomas AJ Jr, Agarwal A (1999) The reactive oxygen species-total antioxidant capacity score is a new measure of oxidative stress to predict male infertility. Hum Reprod 14:2801-2807
33. Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71:2489-2498
34. Sofic E, Froelich L, Riederer P, Jellinger K, Heckers S, Beckmann H, Deinzer E, Pantucek F, Hebenstreit G, Ransmayr G (1991) Biochemical membrane constituents and activity of alkaline and acid phosphatase and cathepsin in cortical and subcortical brain areas of Alzheimer Type. Dementia 2:39-44
35. Sofic E, Rustembegovic A, Kroyer G, Cao G (2002) Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm 109:711-719
36. Sofic E, Sapcanin A, Tahirovic I, Gavrankapetanovic I, Jellinger K, Reynolds GP, Tatschner T, Riederer P (2006) Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases. J Neural Transm Suppl 71:39-43
37. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546
38. Wang CC, Chu CY, Chy KO, Choy KW, Khaw KS, Rogers MS, Pang CP (2004) Trolox equivalent antioxidant capacity assay versus oxygen radical absorbance capacity assay in plasma. Clin Chem 50:952-954